2seventy Bio Stock Z Score
| TSVT Stock | USD 4.80 0.20 4.00% |
2Seventy | Z Score |
2Seventy Bio Company Z Score Analysis
2Seventy Bio's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
2Seventy Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for 2Seventy Bio is extremely important. It helps to project a fair market value of 2Seventy Stock properly, considering its historical fundamentals such as Z Score. Since 2Seventy Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of 2Seventy Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of 2Seventy Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
Based on the company's disclosures, 2Seventy Bio has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
2Seventy Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, 2Seventy Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to 2Seventy Bio's managers, analysts, and investors.Environmental | Governance | Social |
2Seventy Bio Institutional Holders
Institutional Holdings refers to the ownership stake in 2Seventy Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of 2Seventy Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing 2Seventy Bio's value.| Shares | Bain Capital Life Sciences Investors, Llc | 2023-12-31 | 1.3 M | Casdin Capital, Llc | 2023-12-31 | 1.2 M | Eversept Partners, Llc | 2023-12-31 | 1.1 M | Marshall Wace Asset Management Ltd | 2023-12-31 | 1.1 M | Geode Capital Management, Llc | 2023-12-31 | 1.1 M | Jpmorgan Chase & Co | 2023-12-31 | 1 M | Chi Advisors Llc | 2023-09-30 | 1 M | State Street Corporation | 2023-12-31 | 977.6 K | Woodline Partners Lp | 2023-12-31 | 958.7 K | Goldman Sachs Group Inc | 2023-12-31 | 9 M | Kynam Capital Management, Lp | 2023-12-31 | 6 M |
2Seventy Fundamentals
| Return On Equity | -0.73 | ||||
| Return On Asset | -0.21 | ||||
| Operating Margin | (3.91) % | ||||
| Current Valuation | 318.44 M | ||||
| Shares Outstanding | 51.41 M | ||||
| Shares Owned By Insiders | 2.16 % | ||||
| Shares Owned By Institutions | 93.55 % | ||||
| Number Of Shares Shorted | 6.96 M | ||||
| Price To Book | 1.01 X | ||||
| Price To Sales | 2.58 X | ||||
| Revenue | 100.39 M | ||||
| Gross Profit | (183.46 M) | ||||
| EBITDA | (206.42 M) | ||||
| Net Income | (217.57 M) | ||||
| Cash And Equivalents | 357.93 M | ||||
| Cash Per Share | 9.45 X | ||||
| Total Debt | 256.67 M | ||||
| Debt To Equity | 0.73 % | ||||
| Current Ratio | 3.88 X | ||||
| Book Value Per Share | 4.04 X | ||||
| Cash Flow From Operations | (166.86 M) | ||||
| Short Ratio | 6.59 X | ||||
| Earnings Per Share | (4.35) X | ||||
| Target Price | 10.5 | ||||
| Number Of Employees | 274 | ||||
| Beta | 1.87 | ||||
| Market Capitalization | 246.75 M | ||||
| Total Asset | 565.43 M | ||||
| Retained Earnings | (511.22 M) | ||||
| Working Capital | 177.99 M | ||||
| Net Asset | 565.43 M |
About 2Seventy Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 2Seventy Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 2Seventy Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 2Seventy Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with 2Seventy Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if 2Seventy Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 2Seventy Bio will appreciate offsetting losses from the drop in the long position's value.Moving against 2Seventy Stock
| 0.59 | SLS | Sellas Life Sciences | PairCorr |
| 0.48 | MNMD | Mind MedicineInc | PairCorr |
| 0.48 | REVBW | Revelation Biosciences | PairCorr |
The ability to find closely correlated positions to 2Seventy Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace 2Seventy Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back 2Seventy Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling 2Seventy Bio to buy it.
The correlation of 2Seventy Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as 2Seventy Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if 2Seventy Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for 2Seventy Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out 2Seventy Bio Piotroski F Score and 2Seventy Bio Valuation analysis. For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for 2Seventy Stock analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is 2Seventy Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 2Seventy Bio. If investors know 2Seventy will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 2Seventy Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.35) | Revenue Per Share 1.385 | Quarterly Revenue Growth (0.70) | Return On Assets (0.21) | Return On Equity (0.73) |
The market value of 2Seventy Bio is measured differently than its book value, which is the value of 2Seventy that is recorded on the company's balance sheet. Investors also form their own opinion of 2Seventy Bio's value that differs from its market value or its book value, called intrinsic value, which is 2Seventy Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 2Seventy Bio's market value can be influenced by many factors that don't directly affect 2Seventy Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 2Seventy Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 2Seventy Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 2Seventy Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.